Correlation Between Sana Biotechnology and GRI Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sana Biotechnology and GRI Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sana Biotechnology and GRI Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sana Biotechnology and GRI Bio, you can compare the effects of market volatilities on Sana Biotechnology and GRI Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sana Biotechnology with a short position of GRI Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sana Biotechnology and GRI Bio.

Diversification Opportunities for Sana Biotechnology and GRI Bio

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between Sana and GRI is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Sana Biotechnology and GRI Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GRI Bio and Sana Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sana Biotechnology are associated (or correlated) with GRI Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GRI Bio has no effect on the direction of Sana Biotechnology i.e., Sana Biotechnology and GRI Bio go up and down completely randomly.

Pair Corralation between Sana Biotechnology and GRI Bio

Given the investment horizon of 90 days Sana Biotechnology is expected to generate 0.48 times more return on investment than GRI Bio. However, Sana Biotechnology is 2.08 times less risky than GRI Bio. It trades about -0.01 of its potential returns per unit of risk. GRI Bio is currently generating about -0.07 per unit of risk. If you would invest  457.00  in Sana Biotechnology on October 3, 2024 and sell it today you would lose (294.00) from holding Sana Biotechnology or give up 64.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Sana Biotechnology  vs.  GRI Bio

 Performance 
       Timeline  
Sana Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sana Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
GRI Bio 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in GRI Bio are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite fairly conflicting basic indicators, GRI Bio demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Sana Biotechnology and GRI Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sana Biotechnology and GRI Bio

The main advantage of trading using opposite Sana Biotechnology and GRI Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sana Biotechnology position performs unexpectedly, GRI Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GRI Bio will offset losses from the drop in GRI Bio's long position.
The idea behind Sana Biotechnology and GRI Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Transaction History
View history of all your transactions and understand their impact on performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm